EQAs for SARS-Cov-2 and other respiratory viruses open for registration
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
2021 EQA schemes open for registration
We are delivering 90 different EQA schemes covering 8 different core areas of genomics:
- Molecular genetics
- Molecular pathology (including FFPE and plasma based testing)
- Pharmacogenetics
- Technology (e.g NGS)
- Prenatal and Postnatal testing
- Virology
- Interlaboratory Comparisons (sample exchanges).
To browse our catalogue, or download a copy of the participant guide, please follow the link below.
We are a not-for-profit organisation promoting quality in genetic testing by establishing, harmonising and disseminating best practice.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
The latest news and press releases
Email sent in error (Results published of 2019 pilot EQA for CNV analysis using NGS) - https://t.co/1hzMVkNXy4 https://t.co/QoeZtkBi7l
Results published of 2019 pilot EQA for CNV analysis using NGS - https://t.co/q96ZvY96lp https://t.co/or1bwE4c7a
Results published of 2019 pilot EQA for CNV analysis using NGS. Login to your EMQN account to access them (… https://t.co/i3tQ8nRLuT
Validated genotype results have been published for both 2020 NIPT EQA schemes. Please login to your EMQN account to… https://t.co/QjG9d8yXzG
Validated genotype results published today for 2020 BRCA Ovarian and Prostate cancer EQA schemes. Login to your EMQ… https://t.co/LfSOO4THAe